Wasan K, Brocks D, Lee S, Sachs-Barrable K, Thornton S. Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery Nat Rev Drug Discov 7 (1) , 84 - 99 (2008) doi: 10.1038/nrd2353

Wasan K, Risovic V, Sivak O, Lee S, Mason D, Chiklis G, McShane J, Lynn M, Wong N, Rossignol D. Influence of Plasma Cholesterol and Triglyceride Concentrations and Eritoran (E5564) Micelle Size on its Plasma Pharmacokinetics and Ex Vivo Activity Following Single Intravenous Bolus Dose Into Healthy Female Rabbits Pharm Res 25 (1) , 176 - 182 (2008) (Epub 12 Sep 2007) doi: 10.1007/s11095-007-9428-8

BABUDHANIKULA A, MOHAMEDKHALID N, LEE S, YEUNG R, RISOVIC V, WASAN K, LEROUX J. Long circulating lipid nanocapsules for drug detoxification Biomaterials 28 (6) , 1248 - 1257 (2007) doi: 10.1016/j.biomaterials.2006.10.036

Shayeganpour A, Lee S, Wasan K, Brocks D. The Influence of Hyperlipoproteinemia on in Vitro Distribution of Amiodarone and Desethylamiodarone in Human and Rat Plasma Pharm Res 24 (4) , 672 - 678 (2007) (Epub 15 Feb 2007) doi: 10.1007/s11095-006-9186-z

Lee S, Wasan K, Calcagni A, Avery M, McCush F, Chen C. The in Vitro Plasma Distribution of a Novel Cholesteryl Ester Transfer Protein Inhibitor, Torcetrapib, Is Influenced by Differences in Plasma Lipid Concentrations Pharm Res 23 (5) , 1025 - 1030 (2006) (Epub 04 May 2006) doi: 10.1007/s11095-006-9908-2